How much did Neuvivo raise?

Neuvivo raised $1.38 Million in a Seed round on October 30, 2026.

Who are the decision-makers at Neuvivo?

Fundz holds 1 contact at Neuvivo. Names and contact details are shown to Fundz members.

Neuvivo reported raising $1.38 Million in an initial SEC Form D filing, from an offering of $9.5 Million

PRIVATENov 13, 2026$1.4M of $9.5M raised

Amount Raised

$1.38 Million

$1.38 Million sold, per SEC Form D (first sale Oct 30, 2026)

Round Type

Seed

Palo AltoBiotechnology

Quick answer

Neuvivo raised $1.38 Million in a Seed round, dated October 30, 2026. Neuvivo is based in Palo Alto, California, United States.

How much did Neuvivo raise?: Neuvivo raised $1.38 Million in a Seed round on October 30, 2026.
What does Neuvivo do?: Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases.
Where is Neuvivo based and how big is it?: Neuvivo is based in Palo Alto, California, United States.
Who are the decision-makers at Neuvivo?: Fundz holds 1 contact at Neuvivo. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Neuvivo that raised within 45 days of this round, from Fundz verified event records.

Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
XTPL raised $6.5M on November 13, 2026.
BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
PAM2L Biotechnologies raised an undisclosed amount on November 12, 2026.
Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
Biomatter raised $18M (Series A) on November 12, 2026.

Who to call at Neuvivo, and when

A new round usually means Neuvivo is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Neuvivo raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Neuvivo, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neuvivo. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neuvivo

Location

Palo Alto, California, United States

About

Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS. NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neuvivo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Predictive Intelligence

Strategic

ML-powered predictions for Neuvivo's next move

See what Strategic adds

Neuvivo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.